ArticleEcancermedicalscience2012
30th german cancer congress, 22nd-25th february 2012, berlin.
Article in Ecancermedicalscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
"Securing quality - calling for and encouraging research". From 22nd to 25th February 2012 one of the largest multi-disciplinary cancer congresses took place in Berlin, Germany, attended by more than 10,000 healthcare professionals. "The German Cancer Congress is the only interdisciplinary congress of its kind in Germany and the second largest congress of its kind anywhere in the world" stated the congress president Professor Dr P Albers and the president of the German Cancer Society (DKG), Professor Dr Dr h.c. W Hohenberger in their greetings. Only the ASCO Annual Meeting is larger. At the 30th German Cancer Congress (DKK) established national and international experts presented latest data and discussed hot topics in the various oncology fields. Joint Symposia of the DKG together with the UICC (Union for International Cancer Control) and ASCO (American Society of Clinical Oncology) respectively stressed the importance of the meeting. The overreaching theme of the meeting was "Securing quality - calling for and encouraging research". This theme evolved from the idea, that only excellent research in clinics and medical practices can found the basis of future high quality efficient and effective structures in patient care and of the allocation of limited resources to meaningful measures for patient benefit.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.